BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 27, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 13, 2005
View Archived Issues
Targeting of HCV IRES to effectively treat chronic hepatitis C virus infection
Read More
NS-187: dual Bcr-Abl/Lyn inhibitor
Read More
Brivaracetam displays potent anticonvulsant effects in a model of SSSE
Read More
Caspase-1 inhibitors attenuate seizures by blocking brain IL-1beta
Read More
GlaxoSmithKline completes acquisition of ID Biomedical
Read More
AstraZeneca to develop Protherics' CytoFab
Read More
Ono and Dainippon Sumitomo sign new agreement for limaprost alfadex
Read More
New inhibitor of factor VIIa prevents tissue factor-initiated thrombus formation
Read More
Shionogi launches Avelox in Japan
Read More
ZymoGenetics profiles R&D programs
Read More
Cymbalta to be filed for generalized anxiety disorder in 2006
Read More
Canadian clearance for first-in-man study of PPL-100 for drug-resistant HIV
Read More
CK-1827452 selected as development candidate for chronic heart failure
Read More
Phase III ACUITY study of Angiomax completes enrollment
Read More
Treatment begins in phase III study of DX-88 for hereditary angioedema
Read More
Prevention and treatment of mammary tumors with a combination of SERM plus rexinoid
Read More
PSN-9301 effective in reducing glucose levels
Read More
Patient-specific cancer vaccines discussed at hematology meeting
Read More
ISA-247 shows long-term safety in patients with moderate to severe psoriasis
Read More
NG2-73 shown to promote sleepiness
Read More
Novo Nordisk seeks Japanese approval for insulin detemir
Read More
Preclinical efficacy of targeting MTAP as an anticancer strategy
Read More
Novartis receives U.S. regulatory approval to acquire Chiron
Read More
Activation of Nrf2 pathway found to produce antitumorigenic effects in rat liver
Read More
Antiamyloidogenic compound also shown to induce neuritogenesis and neuronal differentiation
Read More
Recent patents reveal novel agents in early development for schizophrenia, depression, etc.
Read More
New treatments for urinary incontinence claimed in recent patents
Read More
Novel therapeutic agents for allergic disorders prepared and tested
Read More
